New research exploring the effects of etanercept on cardiovascular disease in treatment-naive, early RA patients suggests a treatment advantage with etanercept, a TNF inhibitor and methotrexate over treatment with methotrexate and a conventional synthetic disease-modifying anti-rheumatic drug…
![](https://www.the-rheumatologist.org/wp-content/uploads/2016/09/Shutterstock_Generic_RA_500x270-150x150.jpg)